BrainBread 2
Scratch catalog
Screenshots & trailers
Trailers autoplay muted — use controls to unmute.
Primary storefront actions
About this game
CyberCon, the notorious global corporation, aspired to deliver to the world something that would change the fate of humanity. What the world wasn't ready for however... Was CyberCon's true intentions. Their schemes had been controversial to most before, but their newest idea seemed almost too perfect. A much sinister secret was about to be exposed. CyberCon's project involved the development of neuro-hub chips. They succeeded and became a phenomenon, later becoming a mandatory law to have them implanted at birth using state of the art surgery and cutting edge technology.
CyberCon were granted this permission from the government. The controversy was covered up and very little was known how it was done. The technology was seen by many around the world as a major breakthrough that could cure blindness, deafness, disease, and a huge boost in performance for modern day life.
It was further aiding as a gateway to easier communication and enhanced capabilities. This was the next milestone in human history. However, good things must always come to an end.
And CyberCon's true colors are yet to be revealed.
Grab a weapon, demolish your enemies, level up, become more powerful, let the gore flow, let the limbs fly. BrainBread 2 introduces a zombie fps mixed with RPG / Arcade elements, the game is very action-packed and generally fast-paced.
System requirements
PC storefront requirement matrices are shown for the Steam / PC tab. Switch platform above for console release context.
Rarest achievements
Achievements unavailable for this source
This catalog entry does not have a Steam app mapping yet.
Game Snapshot

Platforms
Community rating
Critics rating
Themes
Game modes
Player perspective
Keywords
Languages
Language support isn’t summarized on this overview yet.
- Developer
- Reperio Studios
- Publisher
- Reperio Studios
- Release · Mac
- Worldwide — Jul 20, 2016
Community discussion
Sign in to join the conversation when comments launch.